A Disease Registry of Patients With Mantle Cell Lymphoma

Completed

Conditions studied: Mantle Cell Lymphoma

In brief

The purpose of this study is to create a patient registry in order to assess treatment patterns, physician reported clinical outcomes and patient-reported health-related quality of life among patients diagnosed with Mantle Cell Lymphoma (MCL) who newly initiated a novel therapy in the past 6 months and whose treatment is ongoing at the time of enrollment.

Key facts

Study ID

NCT03816683

Run by

AstraZeneca

People needed

227

Starts

2019-04-01

Expected to finish

2024-03-18

Last updated by the study team

2025-11-14

Who can join

Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient diagnosed with Mantle Cell Lymphoma (MCL)
• Informed consent for participation
• Age ≥ 18 years old, as of the first observed diagnosis of MCL
• Patients for whom a clinical decision has been made to initiate novel therapy in the last 6 months, limited to the following novel agent categories:
• Bcl-2 inhibitors
• BTK inhibitors
• Immunomodulatory agents
• Phosphoinositide 3-kinase inhibitors The novel agent must have been granted approval in at least one haematological cancer. Treatment must be ongoing at the time of enrollment.

You may not qualify if…

• Patient is participating in a clinical study that prohibits participation in non-interventional studies, or where treatment is blinded, at the time of consent.

Where it is running

• Research Site — Montgomery, Alabama, United States
• Research Site — Clovis, California, United States
• Research Site — Boulder, Colorado, United States
• Research Site — Jacksonville, Florida, United States
• Research Site — Pensacola, Florida, United States
• Research Site — Tampa, Florida, United States
• Research Site — Atlanta, Georgia, United States
• Research Site — Augusta, Georgia, United States
• Research Site — Chicago, Illinois, United States
• Research Site — Iowa City, Iowa, United States
• Research Site — Ann Arbor, Michigan, United States
• Research Site — Duluth, Minnesota, United States
• Research Site — Saint Louis Park, Minnesota, United States
• Research Site — Saint Paul, Minnesota, United States
• Research Site — Lincoln, Nebraska, United States
• Research Site — Berkeley Heights, New Jersey, United States
• Research Site — Hackensack, New Jersey, United States
• Research Site — East Syracuse, New York, United States
• Research Site — New York, New York, United States
• Research Site — Eugene, Oregon, United States
• Research Site — Danville, Pennsylvania, United States
• Research Site — Philadelphia, Pennsylvania, United States
• Research Site — Philadelphia, Pennsylvania, United States
• Research Site — Nashville, Tennessee, United States
• Research Site — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.